Company intelligence / Profile preview

Lifebloom

Lille, Hauts-de-France, Francelifebloomcandles.com ↗

Ownership: Private
Development stage: Commercial

Overview

Lifebloom develops an innovative medical device designed to help people with reduced mobility regain strength, balance, and independence in walking. Their exoskeleton approach empowers users to initiate their own muscle activation rather than imposing movement passively. The company has received significant public funding from France’s i-Lab competition and i-Démo program under France 2030 for further R&D and clinical validation of its Everwalk project. Industrialization efforts are underway with plans for efficacy evaluation trials between 2024–2026.

Therapeutic areas: OtherNeurology
Modalities: DeviceExoskeleton
Industry: Assistive Medical Devices

Partnerships

Supported by French government programs including i-Lab/i-Démo grantsworks with ~40 French manufacturers for design-to-production pipeline

Beyond the preview

Go deeper on Lifebloom.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lifebloom.

Explore the full profile